Middle East & Africa Diabetic Foot Ulcer Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)

No. of Pages: 114
Report Code: BMIRE00029573
Category: Life Sciences
Middle East & Africa Diabetic Foot Ulcer Market

The Middle East & Africa diabetic foot ulcer market was valued at US$ 249.80 million in 2022 and is expected to reach US$ 352.45 million by 2030; it is estimated to grow at a CAGR of 4.4% from 2022 to 2030.

High Prevalence of Diabetes and Related Chronic Wounds Fuel the Middle East & Africa Diabetic Foot Ulcer Market

Diabetic patients are vulnerable to wounds, and the healing process is usually longer. Depending on healing timeframe, wounds are classified as acute and chronic. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. According to the International Diabetes Federation (IDF), in 2021, there were ∼537 million adults living with diabetes worldwide. The number is anticipated to increase to 643 million by 2030 and 783 million by 2045. Blood vessels and nerves in the feet of diabetic patients are prone to damages, resulting in numbness. Due to this, diabetic patients have a higher chance of developing diabetic foot ulceration.

According to a study published in 2021 in National Center for Biotechnology Information (NCBI), the risk of developing diabetic foot ulcers is between 19% and 34%. Approximately, a recurrence rate of 40% is experienced by patients within 1 year of recovery, 60% within 3 years, and 65% within 5 years. As per same study, it is reported that infection develops in 50–60% of ulcers and is the principal cause that damages diabetic feet. Thus, the demand for diabetic foot ulcer treatments is on rise globally, thereby fueling the market growth.

Middle East & Africa Diabetic Foot Ulcer Market Overview

The Middle East & Africa diabetic foot ulcer market is estimated to grow at a CAGR of 6.4% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth. In the last few years, the private sector has been playing an important role in the healthcare system in Saudi Arabia, owing to the rising investments in the development of healthcare facilities and infrastructure in the country. The Government of Saudi Arabia launched the Saudi Vision 2030 program to reduce oil dependence and diversify other sectors, including healthcare. Under this program, the Health Sector Transformation Program aims to reconstruct the healthcare sector as a comprehensive, effective, and integrated health system based on the health of individuals. Thus, the increasing investments in developing healthcare facilities and the increasing prevalence of diabetes among the population will fuel the market growth in the Middle East & Africa.

Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Diabetic Foot Ulcer Market Segmentation  

Based on treatment type, the Middle East & Africa diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held the largest share in 2022.

Based on ulcer type, the Middle East & Africa diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held the largest share in 2022.

Based on infection severity, the Middle East & Africa diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held the largest share in 2022.

Based on end user, the Middle East & Africa diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the Middle East & Africa diabetic foot ulcer market is segmented into South Africa, Saudi Arabia, UAE, and the Rest of MEA. South Africa dominated the Middle East & Africa diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the Middle East & Africa diabetic foot ulcer market.    

Middle East & Africa Diabetic Foot Ulcer Market Strategic Insights

global-market-strategic-framework
Get more information on this report

Middle East & Africa Diabetic Foot Ulcer Market Segmentation Analysis

Middle East & Africa Diabetic Foot Ulcer Market Report Highlights

Middle East & Africa Diabetic Foot Ulcer Report Scope

Report Attribute Details
Market size in 2022 US$ 249.80 Million
Market Size by 2030 US$ 352.45 Million
CAGR (2022 - 2030) 4.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Ulcer Type
  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic Ulcers
By Treatment Type
  • Advanced Wound Care Dressings
  • Biologics
  • Therapy Device
By Infection Severity
  • Mild
  • Moderate
  • Severe
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care
Regions and Countries Covered
Middle East and Africa South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa
Market leaders and key company profiles
  • Convatec Group Plc
  • 3M Co
  • Coloplast AS
  • Smith & NephewPlc
  • B.Braun SE
  • Medline Industries LP
  • Organogenesis Inc.
  • Mölnlycke Health Care AB
  • MiMedx Group Inc
Get more information on this report

Middle East & Africa Diabetic Foot Ulcer Market Country and Regional Insights

middle-east-and-africa-diabetic-foot-ulcer-market
Get more information on this report
The List of Companies - Middle East & Africa Diabetic Foot Ulcer Market 1. Convatec Group Plc2. 3M Co3. Coloplast AS4. Smith & Nephew Plc5. B. Braun SE6. Medline Industries LP7. Organogenesis Inc.8. Mölnlycke Health Care AB9. MiMedx Group Inc
Frequently Asked Questions
How big is the Middle East & Africa Diabetic Foot Ulcer Market?

The Middle East & Africa Diabetic Foot Ulcer Market is valued at US$ 249.80 Million in 2022, it is projected to reach US$ 352.45 Million by 2030.

What is the CAGR for Middle East & Africa Diabetic Foot Ulcer Market by (2022 - 2030)?

As per our report Middle East & Africa Diabetic Foot Ulcer Market, the market size is valued at US$ 249.80 Million in 2022, projecting it to reach US$ 352.45 Million by 2030. This translates to a CAGR of approximately 4.4% during the forecast period.

What segments are covered in this report?

The Middle East & Africa Diabetic Foot Ulcer Market report typically cover these key segments-

  • Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-ischemic Ulcers)
  • Treatment Type (Advanced Wound Care Dressings, Biologics, Therapy Device)
  • Infection Severity (Mild, Moderate, Severe)
  • End User (Hospitals, Ambulatory Surgery Centers, Home Care)

What is the historic period, base year, and forecast period taken for Middle East & Africa Diabetic Foot Ulcer Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Diabetic Foot Ulcer Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa Diabetic Foot Ulcer Market?

    The Middle East & Africa Diabetic Foot Ulcer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Convatec Group Plc
  • 3M Co
  • Coloplast AS
  • Smith & NephewPlc
  • B.Braun SE
  • Medline Industries LP
  • Organogenesis Inc.
  • Mölnlycke Health Care AB
  • MiMedx Group Inc
  • Who should buy this report?

    The Middle East & Africa Diabetic Foot Ulcer Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Diabetic Foot Ulcer Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Sales Assistance
    +1 646 791 7070 (US & UK)
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)